Linoleic acid metabolism

Linoleic acid metabolism encompasses the enzymatic processes that convert linoleic acid into a series of polyunsaturated fatty acid derivatives, including arachidonic acid, which serves as a precursor for pro- and anti-inflammatory eicosanoids, endocannabinoids, and oxylipins. These metabolites mediate a wide array of biological functions such as inflammation regulation, cell signaling, vascular tone, and energy metabolism. Enzymes involved in the linoleic acid metabolic pathway—including phospholipase A2, desaturases, elongases, lipoxygenases, cyclooxygenases, and cytochrome P450 family members—are subject to complex regulation, and disturbances in this pathway are implicated in diseases such as cancer, cardiovascular disease, and metabolic syndrome. Notably, "linoleic acid metabolism" itself is a pathway, not a discrete molecular entity, and should not be interpreted as a canonical drug target[1][3][7][9].

Other names

Linoleic acid metabolic pathwayLA metabolism

Inhibition of soluble epoxide hydrolase (sEH), reducing cardiotoxic/oxidative LA metabolites Inhibition of cyclooxygenase/lipoxygenase pathways affects pro-inflammatory eicosanoid production Dietary modulation (LA supplementation or restriction) alters abundance of downstream metabolites and inflammatory status